Free Trial

Rockefeller Capital Management L.P. Has $101.80 Million Holdings in Danaher Co. (NYSE:DHR)

Danaher logo with Medical background

Rockefeller Capital Management L.P. increased its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 3.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 443,422 shares of the conglomerate's stock after acquiring an additional 12,834 shares during the period. Rockefeller Capital Management L.P. owned approximately 0.06% of Danaher worth $101,801,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Heck Capital Advisors LLC bought a new stake in Danaher during the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher during the fourth quarter valued at $31,000. Golden State Wealth Management LLC purchased a new position in Danaher in the 4th quarter worth about $31,000. Strategic Financial Concepts LLC purchased a new stake in Danaher during the fourth quarter valued at about $31,000. Finally, Pineridge Advisors LLC increased its position in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Wells Fargo & Company cut their target price on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Thursday, January 30th. Barclays raised shares of Danaher from an "equal weight" rating to an "overweight" rating and reduced their price target for the stock from $240.00 to $205.00 in a research report on Thursday, April 10th. Robert W. Baird set a $231.00 target price on shares of Danaher in a research report on Wednesday. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Finally, JPMorgan Chase & Co. dropped their target price on Danaher from $310.00 to $300.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Four investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $274.81.

Check Out Our Latest Research Report on DHR

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 11.10% of the company's stock.

Danaher Price Performance

Shares of NYSE:DHR traded down $2.38 during midday trading on Thursday, reaching $188.28. 1,831,165 shares of the company's stock were exchanged, compared to its average volume of 4,476,719. The firm has a market capitalization of $134.57 billion, a PE ratio of 35.69, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The company's 50 day simple moving average is $202.61 and its two-hundred day simple moving average is $228.47. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the company posted $2.09 EPS. Equities research analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is an increase from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Friday, March 28th. Danaher's dividend payout ratio (DPR) is currently 24.24%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Articles

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines